The Cigna Group (CI)
The Cigna Group (CI) is a global health service company that provides insurance plans, related products, and services. It offers health, dental, vision, and pharmacy plans, along with behavioral health services and wellness programs. Founded in 1982 and based in Bloomfield, Connecticut, Cigna focuses on improving health outcomes and enhancing the healthcare experience for individuals and organizations.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 18, 2025 | $1.51 | 2025-09-04 | 2025-09-04 |
| June 18, 2025 | $1.51 | 2025-06-03 | 2025-06-03 |
| March 20, 2025 | $1.51 | 2025-03-05 | 2025-03-05 |
| December 19, 2024 | $1.40 | 2024-12-04 | 2024-12-04 |
| September 19, 2024 | $1.40 | 2024-09-04 | 2024-09-04 |
Dividends Summary
- The Cigna Group has issued 48 dividend payments over the past 21 years
- The most recent dividend was paid 2 days ago, on September 18, 2025
- The highest dividend payed out to investors during this period was $1.51 per share
- The average dividend paid during this period was $0.51 per share.
Company News
BofA Securities highlighted Cigna's strong EPS growth potential and investment in Shields Health Solutions, while expressing cautious views on UnitedHealth and Centene due to potential regulatory and margin challenges.
Cigna Group reported strong Q2 2025 financial results, with revenue of $67.2 billion and adjusted EPS of $7.20, exceeding analyst expectations. The company experienced revenue growth in Evernorth Health Services, though profit margins narrowed, and completed a Medicare business divestiture.
CP Center, a premier business building in Beijing's CBD, hosted an International Cuisine Tasting and Cultural Festival, showcasing its role as a global business hub and highlighting its diverse international tenant mix and innovative business ecosystem.
The executive order aims to lower drug prices in the U.S. by targeting pharmacy benefit managers (PBMs) and their opaque pricing practices. While this could negatively impact PBM companies, pharmaceutical manufacturers may be able to avoid the worst of the price cuts by partnering with PBMs or selling directly to consumers.
Centene Corporation is set to report its second-quarter 2024 results. The company's performance is expected to have benefited from enhanced volumes and contributions from its Commercial business, but declining total memberships and growing cost ratio might affect second-quarter profits.
